Compare SKWD & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SKWD | QDEL |
|---|---|---|
| Founded | 2007 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2022 | 2022 |
| Metric | SKWD | QDEL |
|---|---|---|
| Price | $42.97 | $16.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $65.33 | $32.75 |
| AVG Volume (30 Days) | 492.8K | ★ 1.2M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.81 | ★ 45.35 |
| EPS | ★ 4.07 | N/A |
| Revenue | $1,416,541,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $30.81 | $3.51 |
| Revenue Next Year | $12.09 | $3.86 |
| P/E Ratio | $10.11 | ★ N/A |
| Revenue Growth | ★ 23.16 | N/A |
| 52 Week Low | $40.60 | $15.08 |
| 52 Week High | $65.05 | $37.24 |
| Indicator | SKWD | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 34.67 |
| Support Level | N/A | N/A |
| Resistance Level | $49.64 | $30.65 |
| Average True Range (ATR) | 1.38 | 1.17 |
| MACD | -0.55 | -0.09 |
| Stochastic Oscillator | 26.16 | 25.69 |
Skyward Specialty Insurance Group Inc is a specialty insurance company that offers a suite of specialized insurance solutions across specialty property and casualty markets on a non-admitted and admitted basis. Its portfolio of insurance offerings covers a wide variety of risks, including general liability, commercial auto, group accident and health, property, agriculture, credit, surety, and workers' compensation, among others. Geographically, the group mainly operates in the United States.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.